➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Johnson and Johnson
Dow
Medtronic
Express Scripts

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 5,128,451

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 5,128,451
Title: Protein V:AIgG binding factor
Abstract:A novel bacterial proteinaceous immunoglobulin G receptor is disclosed. The proteinaceous factor binds all four subclasses of human IgG, as well as rabbit, swine, equine, bovine, sheep, and goat IgG. The proteinaceous factor is obtained from biologically pure cultures of Gardnerella vaginalis such as those having the identifying characteristics of ATCC Deposit No. 55195.
Inventor(s): Allen; John W. (Chapel Hill, NC)
Assignee:
Application Number:07/733,219
Patent Claims:see list of patent claims

Details for Patent 5,128,451

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Csl Behring Ag CARIMUNE, CARIMUNE NF, PANGLOBULIN, SANDOGLOBULIN immune globulin intravenous (human) For Injection 102367 2000-07-27 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2007-07-26 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2009-10-02 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2013-02-07 ⤷  Try it Free 2040-01-28
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 2009-09-17 ⤷  Try it Free 2040-01-28
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 2017-02-06 ⤷  Try it Free 2040-01-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Medtronic
Merck
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.